Related Experiment Videos
Ocular metastases from breast carcinoma
Alberto Mejía-Novelo1, Alberto Alvarado-Miranda, Flavia Morales-Vázquez
1Instituto Nacional de Cancerologia, México City.
Medical Oncology (Northwood, London, England)
|October 1, 2004
Summary
Breast cancer commonly spreads to the eye, causing vision loss. Early recognition of these ocular metastases is crucial for improving patient quality of life and visual function.
Area of Science:
- Ophthalmology
- Oncology
Background:
- Intraocular metastases are the most common eye malignancy, frequently originating from breast cancer.
- Breast cancer is the leading cause of ocular metastases, impacting visual function and quality of life.
Purpose of the Study:
- To report the clinical experience of ocular metastases in breast cancer patients.
- To analyze the clinical presentation, treatment, and outcomes of eye metastases from breast cancer.
Main Methods:
- Retrospective analysis of 16 patients with ocular metastases from breast cancer.
- Data collected from January 1991 to December 2002 at a tertiary referral center.
- Evaluation of clinical symptoms, treatment modalities (radiation), and survival.
Main Results:
- Median time to ocular metastases was 22.5 months post-breast cancer diagnosis.
- Common symptoms included decreased visual acuity and ocular pain.
- Radiation therapy showed a clinical response in 4/15 eyes, with significant pain relief in 3 patients.
Conclusions:
- Early detection of ocular metastases in breast cancer patients is vital.
- Prompt recognition and management can preserve visual function and enhance quality of life.
- Improved breast cancer prognosis necessitates attention to metastatic complications like eye involvement.